Pulike Biological Engineering, Inc. (SHSE: 603566)
Health Care · Pharmaceuticals · CN
CN¥10.24
+0.49% today · -25.9% 1Y
Pulike Biological Engineering, Inc. (SHSE: 603566) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $521.97M and employs 1,519 people.
Over the last twelve months the share price has lost 25.9%, trading between 9.56 and 14.58.
Tweenvest scores Pulike Biological Engineering, Inc. across four factors: quality 74/100, value 62/100, growth 42/100, dividend 81/100. Its strongest factor is dividend.
603566 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $521.97M
- Revenue (TTM)
- $150.41M
- P/E
- 23.81
- EPS
- 0.43
- Dividend yield
- 5.86%
- Beta (5Y)
- 0.32
- 52-week high
- CN¥14.58
- 52-week low
- CN¥9.56
- Avg volume (3M)
- —
- Shares outstanding
- 341.92M
- Employees
- 1,519
- Next earnings
- —
About Pulike Biological Engineering, Inc.
Pulike Biological Engineering, Inc. focuses on the entire lifecycle of animal health products, from scientific innovation and manufacturing to market distribution. The company provides a range of veterinary biologicals and pharmaceuticals, including specialized vaccines, antibodies, and medications developed for swine and poultry. Additionally, it produces various disinfectants. Its corporate headquarters are located in Luoyang, China.
- ISIN
- CNE1000025N0
- Founded
- 1995
- Listed since
- May 18, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zeria Pharmaceutical Co., Ltd.TSE: 4559 | $530.44M | ¥1,898.00 | -6.73% |
| Ocumension TherapeuticsSEHK: 1477 | $529.93M | HK$5.10 | -2.76% |
| Boryung CorporationKOSE: A003850 | $525.96M | ₩8,420.00 | +1.69% |
| Beximco Pharmaceuticals PLC.DSE: BXPHARMA | $523.77M | Tk144.60 | +1.40% |
| Orchid Pharma LimitedNSEI: ORCHPHARMA | $521.52M | Rs990.00 | -7.03% |
| Shanghai Shen Lian Biomedical CorporationSHSE: 688098 | $517.91M | CN¥8.46 | +1.08% |
| Gujarat Themis Biosyn LimitedBSE: 506879 | $516.86M | Rs382.35 | -8.38% |
| Tilray Brands, Inc.NasdaqGS: TLRY | $516.28M | $3.59 | -3.36% |
Figures last refreshed Oct 4, 2026.